Oramed醫藥 ORMP 深 滬
等待開盤 10-30 09:30:00 美东时间
2.37
+0.010
+0.42%
華盛通- 最 高2.415
- 今 開2.33
- 成交量 9.07万股
- 最 低 2.326
- 昨 收 2.36
- 總市值 9717.85万
- 52周最高 3.09
- 市盈率 靜 17.40
- 換手率 0.22%
- 52周最低 1.82
- 委 比 85.16%
- 總股本 4100.36万
- 歷史最高 31.73
- 量 比 0.65
- 振 幅 3.77%
- 歷史最低 0.20
- 每 手 1
- 風險率 0.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Oramed Pharm Completes Warrant Repurchase Agreement
Oramed Pharm ( ($ORMP) ) has provided an announcement. On September 30, 2025, O...
10-06 21:49
Ormat Technologies, Inc. to Host Conference Call Announcing Third Quarter 2025 Financial Results
** Ormat Technologies, Inc. announced it will release its Q3 financial results on November 3, 2025, followed by a conference call on November 4, 2025, at 9:00 a.m. ET. Participants can join by dialing 1-800-715-9871 (U.S./Canada) or +1-646-960-0440 (international), using access code 3818407. The call will also be webcast live and archived on the Investor Relations section of the Company’s website. A replay will be available one hour after the ca...
10-06 11:30
Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase
Scilex Holding Company repurchased 3,130,000 warrants from Oramed Pharmaceuticals Inc. for $13 million, retaining the option to buy an additional 3,370,000 warrants by December 31, 2025, for $14 million. The company specializes in developing and commercializing non-opioid pain management products for acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases. Its portfolio includes FDA-approved products like ZTlido, ELYXYB,...
10-01 13:00
Oramed Grants Scilex $27M Option To Repurchase Warrants, With Potential Note Extension To 2026
As previously disclosed, on September 21, 2023, Oramed Pharmaceuticals Inc. (the "Company") entered into and consummated the transactions contemplated by a Securities Purchase Agreement (as amended by that certain
07-23 21:47
Oramed Pharm and Scilex Finalize Option Agreement
Oramed Pharm ( ($ORMP) ) just unveiled an announcement. Oramed Pharmaceuticals ...
07-23 20:59
Alpha Tau files to sell 3.46M ordinary shares by selling shareholders
Alpha Tau (NASDAQ:DRTS) filed a prospectus to sale 3.46 million ordinary shares. The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder. This prospectus ...
06-24 05:08
Oramed Pharm Invests $36.9M in Alpha Tau Medical
Oramed Pharm ( ($ORMP) ) just unveiled an update. On April 28, 2025, Oramed Pha...
04-29 05:02
Oramed Expands with New Facility Acquisition
The latest announcement is out from Oramed Pharm ( ($ORMP) ). Oramed has announ...
02-18 14:58
美股牛股 | 保险股SelectQuote绩后飙升逾30%！万国数据隔夜涨超17%，传考虑分拆国际业务赴美上市
保险股SelectQuote绩后飙升逾30%，最新季度业绩超出市场预期；万国数据隔夜涨超17%，传公司考虑分拆国际业务赴美上市>>
02-12 19:45
